The lab automation market is projected to reach USD 5.5 billion by 2025from an estimated USD 4.3billion in 2020, at a CAGR of 5.2% during the forecast period. The growth of the market is attributed to increasing spending on pharmaceutical R&D, growing food safety concerns, stringent regulation in healthcare. Moreover, the growing proteomics market, rising environmental safety concerns, and high demand in emerging nations offer lucrative opportunities for the market players. However, slow adoption of automation among small and medium-sized laboratories owing to the budget constraint are the major factors that are expected to restrain the growth of this market during the forecast period.
The software, by product type, is expected to be the fastest-growing market from 2020 to 2025. The software segment is categorized as LIMS, ELN, LES, and SDMS.LIMS is the fast-growing software during the forecast period. The growth is attributed to the ability of the systems to increase workflow efficiencies by removing manual data entry and transcription errors. Thus, improving work processes , productivity, traceability, sample turnaround time, data security and accountability, ease of access to data, and regulatory compliance.
The biotechnology and pharmaceutical companies, by end user, is expected to be the largest market from 2020 to 2025. The biotechnology and pharmaceutical companies segment is expected to grow at the fastest rate during the forecast period. Owing to the increasing pressure on the biotechnology and pharmaceutical companies to rapidly develop drugs has driven demand for automating laboratory processes in this end-user segment. Moreover, the availability of government and corporate funding for biotech and pharma research is also driving the growth of this industry
North America: The largest and the third fastest-growing region in the lab automation market. North America is expected to dominate the global lab automation market between 2020 and 2025.Increasing diagnostic testing in the region due to the higher penetration of healthcare facilities and growing health awareness. With an increasingly aging population and the rising prevalence of lifestyle diseases, there has been a significant rise in the demand for diagnostics and therapeutics.
Breakdown of Primaries: In-depth interviews have been conducted with various key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information, as well as to assess future market prospects. The distribution of primary interviews is as follows: • By Company Type: Tier 1- 25%, Tier 2- 30%, and Tier 3-45% • By Designation: C-Level- 12%, Director Level- 24%, and Others- 64% • By Region: North America- 34%, Europe- 26%,Asia Pacific- 35%,RoW-5% *Others includes sales managers, engineers, and regional managers. Note: Tier 1 Company—Revenue > USD 5 billion, Tier 2 Company—Revenue between USD 1 and USD 5 billion, and Tier 3 Company—Revenue < USD 1 billion The lab automation market is dominated by a few major players that have an extensive regional presence. The leading players in the lab automation market are Thermo Fisher Scientific(US), Agilent Technologies(US),Tecan Group (Switzerland),PerkinElmer Inc. (US)and Danaher Corporation (US).
Study Coverage: The report defines, describes, and forecasts the lab automation market, by technology, application, and region.It also offers a detailed qualitative and quantitative analysis of the market.
The report provides a comprehensive review of the major market drivers, restraints, opportunities, and challenges. It also covers various important aspects of the market, which include the analysis of the competitive landscape, market dynamics, market estimates in terms of value, and future trends in the lab automation market.
Key Benefits of Buying the Report 1. The report identifies and addresses the key markets for lab automation operations and services, which would help equipment manufacturers and service providers review the growth in demand. 2. The report helps system providers understand the pulse of the market and provides insights into drivers, restraints, opportunities, and challenges. 3. The report will help key players understand the strategies of their competitors better and help them in making better strategic decisions.
Our reports have been used by over 10K customers, including:
The POC data management software market was valued at USD 5916.9 million in 2019, and it is expected to reach a value of USD 11,772.2 million by 2025, registering a CAGR of 12.3% over the forecast period from 2020 to 2025. Point-of-care technologies enable hospitals and clinics to invest more time and money in technologies that help accelerate...
The global chromatography instruments market is projected to reach USD 11.0 billion by 2025 from USD 8.6 billion in 2020 at a CAGR of 5.1%. Growth in the chromatography instruments market can be attributed to increasing investments by pharma and biotech companies in R&D activities, growing demand for hyphenated chromatography techniques, and...
The women’s health diagnostics market is projected to reach USD 36.6 billion by 2025 from USD 25.0 billion in 2020, at a CAGR of 7.9% during the forecast period. In the past decade, the demand for various health diagnostic tests has increased significantly across the globe. Currently, the market is mainly driven by growing awareness about...
Traditional aggregometer work on the principle of light transmission. The traditional aggregometer performs light transmission aggregometry (LTA) which was once considered as the gold standard for platelet function testing and is still used for the identification and diagnosis of platelet function defects. Traditional LTA remains the most...
The chiral chromatography columnmarketsize is projected to reach USD 123 million by 2025 from an estimated USD 99 million in 2020, at a CAGR of4.5% during the forecast period. Increasing R&D investments in the pharmaceutical and biotechnology industry is creating demand opportunities for the chiral chromatography column industry. Also,increasing...
The global point of care diagnostrics market size is projected to reach USD 50.6 billion by 2025 from USD 29.5 billion in 2020, at a CAGR of 11.4%. Factors such as the technological advancements in point of care devices in the market are propelling the growth of the market. Additionally, rising cases of investments from both private and public...
The major factors responsible for the growth of the mammography market include the growing prevalence of breast cancer, technological advancements in the field of breast imaging, and investment from various organizations in breast cancer screening campaigns. - According to the Centers for Disease Control and Prevention (CDC) reports,...
212 pages •
By Asia Market Information & Development Company
• Feb 2021
China’s demand for Patient Monitoring and Diagnostic Systems has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import...
The nucleic acid amplification, detection, and diagnostics market was valued at US$ 14,014.59 million in 2019 and is projected to reach US$ 38,162.68 million by 2027; it is expected to grow at a CAGR of 13.4% during 2020–2027. The growth of the nucleic acid amplification, detection, and diagnostics market is mainly attributed to the factors...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Rapid Diagnostics Market Report
The rapid diagnostics market by revenue is expected to grow at a CAGR of 10% during the period 2019–2025.
The global rapid diagnostics market is one of the major segments of the global in-vitro diagnostics...
Diagnostics
World
Diabetes Prevalence
Health Expenditure
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.